Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial. Lu P, Liu Y, Yang J, Zhang X, et al. Blood 2022;140:321-334.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lu P, Liu Y, Yang J, Zhang X, et al. Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial. Blood 2022;140:321-334.
PMID: 35500125